Info
Makris, M. et ai. (1997) Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrates on correction of coagulopathy. Thrombosis Haemostasis, 77 477-80.
• Prepared by slow thawing of FFP at 4-6°C. Fresh plasma taken from a single donor is snap frozen then thawed at 4°C and a cryoprecipitate forms.
• Precipitate formed is cryoprecipitate which is then stored at -30°C.
• Rich in factors VIII, XIII, fibrinogen and von Willebrand factor. Per unit (bag):
- Factor VIII and vWF ~80-100iu.
- Fibrinogen ~250mg.
- Factor XIII and fibronectin.
- Does not contain other coagulation factors.
- May contain anti-A and anti-B blood group antibodies.
• Formerly (but no longer) used for management of bleeding in factor VIII deficiency and von Willebrand's disease.
• Main clinical use for cryoprecipitate is as additional support for the clotting defects induced by massive transfusion and DIC.
• All donations are screened for HIV, HBV and HCV.
Post a comment